The pooling analysis results in the Oncomine database further demonstrated that WDR74 is highly expressed in brain and CNS cancer, breast cancer, colorectal cancer, lung cancer, or lymphoma compared with normal controls (Supplementary Figure S6). Here, WDR74 is linked to central nervous system cancer.